|
El-Nasr Pharmaceutical Chemicals company is the first Egyptian company for the production of pharmaceutical raw materials established 1960. It is specialized in manufacturing and trading pharmaceutical products for human and veterinary use. Its capital is approximately 150 million Egyptian pound owned totally by Holdipharma.
It is characterized by manufacturing and trading pharmaceutical specialties, IV solutions, veterinary specialties, haemodialysis concentrates, kidney dialysers, blood lines, fistula needles, bulk chemicals, laboratory chemicals, diagnostics, industrial enzymes and clinical kits. Its annual sales is approximately 181 million Egyptian pounds.
Its Chief Executive Officer is Dr. Shereen Mohamed Fathi El-Kadi.
|
Company Main Indicators (in thousands of Egyptian Pounds) |
|
Indicator |
|
Net Operating Revenue |
|
Interest Expenses |
|
Net Income |
|
Net Equity |
|
Working Capital |
|
Total Investment |
|
Salaries |
|
Number of workers | |
|
2008-2009 |
|
241822 |
|
0 |
|
41087 |
|
222904 |
|
80147 |
|
232904 |
|
57921 |
|
2505 | |
|
2009-2010 |
2010-2011 |
|
238984 |
182783 |
|
0 |
0 |
|
-3609 |
-54715 |
|
219295 |
379952 |
|
33360 |
132162 |
|
229295 |
379952 |
|
62722 |
83296 |
|
2524 |
2551 | | | |